Effects of cyclo-oxygenase inhibition on exhaled eicosanoids in patients with COPD - Test2 - elhamkhani - TriplyDB

Effects of cyclo-oxygenase inhibition on exhaled eicosanoids in patients with COPD

Effects of cyclo-oxygenase inhibition on exhaled eicosanoids in patients with COPD

http://www.wikidata.org/entity/Q35537218

about

Lymphocyte Kv1.3-channels in the pathogenesis of chronic obstructive pulmonary disease: novel therapeutic implications of targeting the channels by commonly used drugs Breath tests in respiratory and critical care medicine: from research to practice in current perspectives Sputum and nasal lavage lung-specific biomarkers before and after smoking cessation.Prostaglandin E2 receptors in asthma and in chronic rhinosinusitis/nasal polyps with and without aspirin hypersensitivity.Biomarkers in exhaled breath condensate: a review of collection, processing and analysis.Increase of nitrosative stress in patients with eosinophilic pneumonia Hemoglobin attenuates the effects of inspired oxygen on plasma isofurans in humans during upper-limb surgery.Ozone modulates IL-6 secretion in human airway epithelial and smooth muscle cells Analysis of exhaled breath condensate in respiratory medicine: methodological aspects and potential clinical applications.Review paper: the role of inflammation in mouse pulmonary neoplasia.COX inhibitors for airway inflammation.Targeting 5-lipoxygenase-activating protein in asthma and chronic obstructive pulmonary disease.Exhaled breath condensate as a source of biomarkers for lung carcinomas. A focus on genetic and epigenetic markers-A mini-review.Chronic obstructive pulmonary disease and neutrophil infiltration: role of cigarette smoke and cyclooxygenase products.Dung biomass smoke activates inflammatory signaling pathways in human small airway epithelial cells.Clarithromycin prevents smoke-induced emphysema in mice.Functional polymorphism of cyclooxygenase-2 gene (G-765C) in chronic obstructive pulmonary disease patients.Development of a fast and simple LC-MS/MS method for measuring the F2-isoprostanes in newborns.Strategies to decrease oxidative stress biomarker levels in human medical conditions: A meta-analysis on 8-iso-prostaglandin F2α.Regional heterogeneity in response of airway epithelial cells to cigarette smoke

P2860

Q28069399-72BA6F76-A28A-4308-B7A4-CAA3D0677172 Q30448113-54B327E5-5F16-4195-BF5D-0BDA43B4DB02 Q33920374-68E1DEE9-4C01-4D38-9CA6-B4546558A68C Q34434995-CA63AF81-FA2A-4AFD-A806-7234F46656E3 Q34684120-EA6ECB34-0A04-4A7B-9577-B33D7DCBC552 Q35121368-605A3C11-686F-41FE-90FC-E34070A8BEA0 Q35167649-10FF75F2-5351-4A90-ACBF-6B87281E848D Q35776527-8017E851-2D26-42A8-BAFF-D17EFCA71F1F Q37362565-0DE3BC73-8137-4D3E-B429-0CD8783A5E44 Q37379547-CDBF85F7-6DE8-494F-87AC-22B9021A2C87 Q37983125-B17A0F45-2D63-4C50-9834-CD89DB4E9DA4 Q38248535-6DF39068-A7BF-42DF-9CC4-2EE661BC85EC Q38915216-A7AA64AB-56EE-46D7-BDD0-2C73C05DBCC6 Q39777516-155D0160-5046-457B-8952-F6F9413CB290 Q40455185-D2F99154-30D1-4517-845B-812C05036C40 Q43652179-2174BCA1-5317-4162-841C-F03BF64236CA Q48855054-62E1B0EC-B582-4083-A6A8-5094024084B6 Q51358982-40C9D5AF-1451-4A1E-B473-EC8408D9D774 Q55279804-E8B171D2-979C-4228-8E90-655A8E166A91 Q58765621-C8726450-89ED-4B92-A227-4BADD10537B3

P2860

Effects of cyclo-oxygenase inhibition on exhaled eicosanoids in patients with COPD

http://www.wikidata.org/entity/Q35537218

description

2005 nî lūn-bûn

@nan

2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Effects of cyclo-oxygenase inhibition on exhaled eicosanoids in patients with COPD

@ast

Effects of cyclo-oxygenase inhibition on exhaled eicosanoids in patients with COPD

@en

type

label

Effects of cyclo-oxygenase inhibition on exhaled eicosanoids in patients with COPD

@ast

Effects of cyclo-oxygenase inhibition on exhaled eicosanoids in patients with COPD

@en

prefLabel

Effects of cyclo-oxygenase inhibition on exhaled eicosanoids in patients with COPD

@ast

Effects of cyclo-oxygenase inhibition on exhaled eicosanoids in patients with COPD

@en

P1433

Q35537218-CCCDAD0C-7ADE-4131-8695-1C557174F166

P1476

Q35537218-7E5A624E-C0BD-4DB1-A502-5380C8756F61

P2093

Q35537218-18551FE4-D854-43CD-B6EC-22106646AF90

Q35537218-39D061C8-330D-40DC-B4E8-1E0F76274EE1

Q35537218-663B2785-5F3A-4E99-A4C7-6B4A6B540718

Q35537218-70131AFE-415A-40D1-965E-93D945E06614

Q35537218-98D741E8-0DFB-465A-96FC-65F125671287

Q35537218-CC5334FC-ABFE-4BE1-82C2-34311746552C

Q35537218-D9BAD58B-68D0-45BF-848B-3813CCC95ED1

Q35537218-FB557A10-BC6C-4D60-AFD0-9FBED0D813B4

Q35537218-FE5F7A98-D414-4363-BC93-5A7B8BC57E3F

P2860

Q35537218-0B965E00-84EA-4687-A84D-39C7FE1E5283

Q35537218-10E532D9-A64A-40AA-A9FE-A91636781E7F

Q35537218-1412F67F-D509-49D9-BFAE-D2DB93212EC2

Q35537218-15731164-1519-45A8-AACE-3947DC4BB1EA

Q35537218-2262F3BF-4C69-4465-AFC9-D38393E6C45E

Q35537218-512B15A6-EF05-4466-82C8-5879972FE040

Q35537218-53BA545F-ADFE-44FB-803F-B2323A66D563

Q35537218-546A8BCF-0C2A-4C24-81EC-0471A95864E4

Q35537218-7144BF4D-94E7-42FB-8BA4-BD11F6FDC8EC

Q35537218-8AEE33B1-BC32-49E8-A077-1FD66EAB0CE6

P304

Q35537218-7424CB80-FDC8-4BD6-9860-A229FEFDAAFC

P31

Q35537218-6C35432B-88BD-467A-BCC0-89104D3E1A00

P356

Q35537218-7A2B4321-1247-4FFF-87D2-A52DDABD1E2D

P407

Q35537218-D2228D46-E843-4A0C-9AC3-0CC625DECCD9

P433

Q35537218-9C7C1C6C-FDF3-4FBC-9375-A3BB14FCE989

P478

Q35537218-7F34B966-C353-4798-AB97-D04B11DD1F8B

P577

Q35537218-D6E9A0C0-1AE3-4AD8-A5B0-3280E02A051A

P5875

Q35537218-99D13085-9B39-40BE-BDD2-1BFB2DA24F93

P698

Q35537218-4DA9C3EA-E417-4A2E-9AD7-ACF684D0EFC6

P932

Q35537218-599D9521-837A-4C2E-949A-927F29CA2AF1

P356

THX.2004.035592

P1433

P1476

Effects of cyclo-oxygenase inhibition on exhaled eicosanoids in patients with COPD

@en

P2093

Barnes PJ

http://www.w3.org/2001/XMLSchema#string

Ciabattoni G

http://www.w3.org/2001/XMLSchema#string

Ciappi G

http://www.w3.org/2001/XMLSchema#string

Kharitonov SA

http://www.w3.org/2001/XMLSchema#string

Lauriola L

http://www.w3.org/2001/XMLSchema#string

Macagno F

http://www.w3.org/2001/XMLSchema#string

Montuschi P

http://www.w3.org/2001/XMLSchema#string

Parente P

http://www.w3.org/2001/XMLSchema#string

Valente S

http://www.w3.org/2001/XMLSchema#string

P2860

A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.

Allergic lung responses are increased in prostaglandin H synthase-deficient mice.

The clinical course of patients with idiopathic pulmonary fibrosis.

Collection and analysis of exhaled breath condensate in humans.

Isoprostanes: markers and mediators of oxidative stress.

Analysis of exhaled breath condensate for monitoring airway inflammation.

Indirect monitoring of lung inflammation.

Sample size for beginners

Effect of inhaled endotoxin on induced sputum in normal, atopic, and atopic asthmatic subjects.

Exhaled leukotrienes and prostaglandins in COPD.

P304

827-833

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/THX.2004.035592

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P577

2005-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7572902

http://www.w3.org/2001/XMLSchema#string

P698

16192367

http://www.w3.org/2001/XMLSchema#string

P932

1747215

http://www.w3.org/2001/XMLSchema#string